Market Dynamics: The global amyloidosis market is poised to experience a robust revenue Compound Annual Growth Rate (CAGR) throughout the forecast period. Factors driving market revenue growth include the continuous development and introduction of more advanced therapeutic drugs for amyloidosis, an increase in genetic susceptibility to amyloidosis among populations, growing awareness regarding...